Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A2b receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | adenosine A1 receptor | 326 aa | 305 aa | 21.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0402 | 1 | 1 | |
Onchocerca volvulus | 0.0402 | 1 | 1 | |
Onchocerca volvulus | 0.0402 | 1 | 1 | |
Onchocerca volvulus | 0.0402 | 1 | 1 | |
Onchocerca volvulus | 0.0402 | 1 | 1 | |
Onchocerca volvulus | 0.0402 | 1 | 1 | |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0402 | 1 | 1 |
Brugia malayi | LBP / BPI / CETP family, N-terminal domain containing protein | 0.0402 | 1 | 1 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0402 | 1 | 1 |
Onchocerca volvulus | 0.0402 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0402 | 1 | 1 |
Onchocerca volvulus | 0.0402 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Binding affinity to human N-terminal sig-SNAP-tagged adenosine A3 receptor expressed in HEK293 cells co-expressing adenosine A2B receptor assessed as intracellular fluorescence level at 5 nM after 10 mins by confocal microscopic analysis in presence of MRS1220 | ChEMBL. | 22277057 | |
Activity (binding) | Binding affinity to human full length human adenosine A1 receptor expressed in CHO cells up to 100 nM after 10 mins by confocal microscopic analysis | ChEMBL. | 22277057 | |
Activity (binding) | Binding affinity to human N-terminal sig-SNAP-tagged adenosine A3 receptor expressed in HEK293 cells co-expressing adenosine A2B receptor assessed as intracellular fluorescence level at 5 nM after 10 mins by confocal microscopic analysis | ChEMBL. | 22277057 | |
Activity (binding) | Binding affinity to human N-terminal sig-SNAP-tagged adenosine A3 receptor expressed in HEK293 cells co-expressing adenosine A2B receptor assessed as intracellular fluorescence level at 5 nM after 10 mins by confocal microscopic analysis in presence of PSB603 | ChEMBL. | 22277057 | |
Activity (binding) | Binding affinity to human adenosine A3 receptor expressed in CHO cells assessed as intracellular fluorescence level after 10 mins by confocal microscopic analysis in presence of MRS1220 treated 30 mins before compound challenge | ChEMBL. | 22277057 | |
Activity (binding) | Binding affinity to human full length human adenosine A1 receptor expressed in CHO cells at 25 nM after 10 mins by confocal microscopic analysis | ChEMBL. | 22277057 | |
Activity (binding) | Binding affinity to human adenosine A3 receptor expressed in CHO cells assessed as intracellular fluorescence level after 10 mins by confocal microscopic analysis | ChEMBL. | 22277057 | |
Kd (functional) | < 6 | Antagonist activity at adenosine A2B receptor in HEK293 cells expressing glosensor cAMP biosensor assessed as inhibition of NECA-induced increase of intracellular cAMP level after 5 hrs | ChEMBL. | 22277057 |
Kd (functional) | = 6.56 | Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced increase of intracellular cAMP level after 5 hrs | ChEMBL. | 22277057 |
Kd (functional) | = 9.36 | Antagonist activity at human adenosine A3 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of NECA-induced CRE-SPAP gene transcription by measuring intracellular cAMP level after 5 hrs | ChEMBL. | 22277057 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.